CStone Presented Preclinical Data for Three Novel or Differentiated ADCs at AACR 2026, Including CS5007 (EGFR/HER3)prnewswire.com
Pulnovo Medical Announces Strategic Investment from Medtronic in oversubscribed $100 Million Financing Roundprnewswire.com
Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meetingglobenewswire.com
Pulnovo Medical Announces Strategic Investment from Medtronic in oversubscribed $100 Million Financing Roundprnewswire.com
Faraday Future Announces $45 Million in New Financing with a U.S. Institutional Investor to Strongly Support the Execution of Its EAI Robotics & EAI EV Business; Plans to Pursue Long-Term Strategic Cooperation with the Investor for Mutual Benefitbusinesswire.com
Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stockaccessnewswire.com
SK hynix Begins Mass Production of 192GB SOCAMM2 'Setting a New Standard for AI Server Memory Performance'prnewswire.com
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLNOnewsfilecorp.com
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuitprnewswire.com
Defense Stock Face-Off: Lockheed Martin vs. Howmet Aerospace -- Which Is the Better Buy Right Now?fool.com
ROSEN, LEADING GLOBAL COUNSEL, Encourages Pinterest, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action- PINSnewsfilecorp.com
SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stockbusinesswire.com
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Camping World Holdings, Inc. to Secure Counsel Before Important Deadline in Securities Class Action - CWHnewsfilecorp.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSXnewsfilecorp.com
Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026globenewswire.com
Amplitude Research Reveals a Generational AI Trust Gap is Costing Australian Businessesbusinesswire.com